When Hugh Martin, the chief executive of gene sequencing start-up Pacific Biosciences, discovered that he had multiple myeloma, he bent over backward to disclose the fact to his entire company in excruciating detail, and also to his investors, his business partners, and Fortune, which ran a story about the way he handled the decision.
FORBES: The Medical Mismeasure of Steve Jobs